Literature DB >> 32373651

Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders.

Stella M Papa1, Patrik Brundin2, Victor S C Fung3, Un Jung Kang4, David J Burn5, Carlo Colosimo6, Han-Lin Chiang7, Roy N Alcalay8, Claudia Trenkwalder9.   

Abstract

Entities:  

Keywords:  COVID‐19; Parkinson's disease; SARS‐CoV‐2; coronavirus; movement disorders; pandemic

Year:  2020        PMID： 32373651      PMCID： PMC7197322          DOI： 10.1002/mdc3.12953

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  27 in total

1.  Influence of Parkinsonism on outcomes of elderly pneumonia patients.

Authors:  Taisuke Jo; Hideo Yasunaga; Nobuaki Michihata; Yusuke Sasabuchi; Wakae Hasegawa; Hideyuki Takeshima; Yukiyo Sakamoto; Hiroki Matsui; Kiyohide Fushimi; Takahide Nagase; Yasuhiro Yamauchi
Journal:  Parkinsonism Relat Disord       Date:  2018-04-03       Impact factor: 4.891

Review 2.  Can infections trigger alpha-synucleinopathies?

Authors:  Christopher T Tulisiak; Gabriela Mercado; Wouter Peelaerts; Lena Brundin; Patrik Brundin
Journal:  Prog Mol Biol Transl Sci       Date:  2019-07-03       Impact factor: 3.622

3.  Evidence for an enterovirus as the cause of encephalitis lethargica.

Authors:  Robert R Dourmashkin; Glynis Dunn; Victor Castano; Sherman A McCall
Journal:  BMC Infect Dis       Date:  2012-06-20       Impact factor: 3.090

4.  Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4.

Authors:  Kun Li; Christine Wohlford-Lenane; Stanley Perlman; Jincun Zhao; Alexander K Jewell; Leah R Reznikov; Katherine N Gibson-Corley; David K Meyerholz; Paul B McCray
Journal:  J Infect Dis       Date:  2015-10-20       Impact factor: 5.226

5.  The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.

Authors:  Nolwen L Rey; Daniel W Wesson; Patrik Brundin
Journal:  Neurobiol Dis       Date:  2016-12-20       Impact factor: 5.996

6.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.

Authors:  Roujian Lu; Xiang Zhao; Juan Li; Peihua Niu; Bo Yang; Honglong Wu; Wenling Wang; Hao Song; Baoying Huang; Na Zhu; Yuhai Bi; Xuejun Ma; Faxian Zhan; Liang Wang; Tao Hu; Hong Zhou; Zhenhong Hu; Weimin Zhou; Li Zhao; Jing Chen; Yao Meng; Ji Wang; Yang Lin; Jianying Yuan; Zhihao Xie; Jinmin Ma; William J Liu; Dayan Wang; Wenbo Xu; Edward C Holmes; George F Gao; Guizhen Wu; Weijun Chen; Weifeng Shi; Wenjie Tan
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

7.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

8.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Authors:  Nanshan Chen; Min Zhou; Xuan Dong; Jieming Qu; Fengyun Gong; Yang Han; Yang Qiu; Jingli Wang; Ying Liu; Yuan Wei; Jia'an Xia; Ting Yu; Xinxin Zhang; Li Zhang
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

9.  The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.

Authors: 
Journal:  Nat Microbiol       Date:  2020-03-02       Impact factor: 17.745

10.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245
View more
  11 in total

1.  Potential impact and challenges associated with Parkinson's disease patient care amidst the COVID-19 global pandemic.

Authors:  Ali Elbeddini; Anthony To; Yasamin Tayefehchamani; Cindy Wen
Journal:  J Clin Mov Disord       Date:  2020-08-08

Review 2.  Impact of Covid-19 on research and training in Parkinson's disease.

Authors:  Yi-Min Wan; Daniel J van Wamelen; Yue Hui Lau; Silvia Rota; Eng-King Tan
Journal:  Int Rev Neurobiol       Date:  2022-05-04       Impact factor: 4.280

Review 3.  Histopathological and molecular links of COVID-19 with novel clinical manifestations for the management of coronavirus-like complications.

Authors:  Ankita Sood; Onkar Bedi
Journal:  Inflammopharmacology       Date:  2022-05-30       Impact factor: 5.093

4.  Neurologic Manifestations of COVID-19.

Authors:  Farnaz Delavari; Farnaz Najmi Varzaneh; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Movement Disorders Induced by SARS-CoV-2 Infection: Protocol for a Scoping Review.

Authors:  Elena Cecilia Rosca; Zsolt Vastag; Onanong Phokaewvarangkul; Jirada Sringean
Journal:  J Clin Med       Date:  2022-02-10       Impact factor: 4.241

6.  Loss of mitochondrial membrane potential (ΔΨm ) in leucocytes as post-COVID-19 sequelae.

Authors:  Karina Janice Guadalupe Díaz-Resendiz; Alma Betsaida Benitez-Trinidad; Carlos Eduardo Covantes-Rosales; Gladys Alejandra Toledo-Ibarra; Pablo Cesar Ortiz-Lazareno; Daniel Alberto Girón-Pérez; Adela Yolanda Bueno-Durán; Daniela Alejandra Pérez-Díaz; Rocío Guadalupe Barcelos-García; Manuel Iván Girón-Pérez
Journal:  J Leukoc Biol       Date:  2022-03-31       Impact factor: 6.011

Review 7.  COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?

Authors:  Luigi Ferini-Strambi; Maria Salsone
Journal:  J Neurol       Date:  2020-07-21       Impact factor: 4.849

8.  Impact of home confinement during COVID-19 pandemic on Parkinson's disease.

Authors:  Niraj Kumar; Ravi Gupta; Hrishikesh Kumar; Sahil Mehta; Roopa Rajan; Deva Kumar; Rukmini Mridula Kandadai; Soaham Desai; Pettarusp Wadia; Purba Basu; Banashree Mondal; Ankita Rawat; Sai Srilakshmi Meka; Bhushan Mishal; L K Prashanth; Achal Kumar Srivastava; Vinay Goyal
Journal:  Parkinsonism Relat Disord       Date:  2020-09-06       Impact factor: 4.891

9.  COVID-19 in Parkinson's Disease Patients Living in Lombardy, Italy.

Authors:  Alfonso Fasano; Emanuele Cereda; Michela Barichella; Erica Cassani; Valentina Ferri; Anna Lena Zecchinelli; Gianni Pezzoli
Journal:  Mov Disord       Date:  2020-06-26       Impact factor: 9.698

10.  Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross-Sectional Survey of 568 Spanish Patients.

Authors:  Diego Santos-García; Mila Oreiro; Patricia Pérez; Gemma Fanjul; Jose Manuel Paz González; María José Feal Painceiras; Carlos Cores Bartolomé; Lorena Valdés Aymerich; Carlos García Sancho; Maria Del Mar Castellanos Rodrigo
Journal:  Mov Disord       Date:  2020-09-22       Impact factor: 9.698
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.